Werewolf Therapeutics, Inc. (HOWL) Social Stream



Werewolf Therapeutics, Inc. (HOWL): $4.14

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HOWL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Werewolf Therapeutics Inc (HOWL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering HOWL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 5 $32 $22 $26.4 $4.4 500%
2022-03-25 5 $32 $22 $26.2 $4.4 495.45%
2022-03-27 5 $32 $9 $22.8 $4.4 418.18%

The Trend in the Analyst Price Target


Over the past 36 weeks, HOWL's average price target has gone down $3.7.

HOWL reports an average of 115.25% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-25 3 32 22 26.5 14.83 78.69%
2021-07-03 3 32 22 26.5 20.31 30.48%
2021-09-10 5 32 22 26.4 17.05 54.84%
2021-09-14 5 32 22 26.4 17.14 54.03%
2021-11-12 5 32 22 26.4 16.04 64.59%

HOWL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 43 weeks, HOWL's average broker recommendation rating improved by 0.33.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HOWL as an investment opportunity.

  • In terms of how Werewolf Therapeutics Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 287.51% of that group.
  • HOWL has a lower variance in analysts' estimates than -42.82% of Pharmaceutical Products stocks.
  • Werewolf Therapeutics Inc's number of analysts covering the stock is greater than 192.03% of stocks in the small market cap category.
  • Werewolf Therapeutics Inc's average analyst price target is greater than 119.92% of Healthcare stocks.

In the Pharmaceutical Products industry, HGEN, GTHX, and GRTX are the three stocks most similar to Werewolf Therapeutics Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for HOWL? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3976 seconds.